A recent report published by
Infinium Global Research on post operative nausea and vomiting market provides
in-depth analysis of segments and sub-segments in the global as well as
regional post operative nausea and vomiting market. The study also highlights
the impact of drivers, restraints, and macro indicators on the global and
regional post operative nausea and vomiting market over the short term as well
as long term. The report is a comprehensive presentation of trends, forecast
and dollar values of the global post operative nausea and vomiting market.
According to the report, the global post operative nausea and vomiting market is
projected to grow at a CAGR of 8.38% over the forecast period of 2021-2027.
The global post operative nausea
and vomiting market size to grow from USD 1.92 billion in 2020 to USD 3.32 billion
by 2027, at a CAGR of 8.4% during the forecast period. Post operative nausea
and vomiting are uncomfortable for patients and can lead to more serious
complications. It is an enormous problem for patients recovering after surgery.
About 30% of people experience vomiting and 50% experience nausea. As many as
80% of high-risk individuals may experience post operative nausea and vomiting.
Post operative nausea and vomiting
(PONV) are amongst the most frequently occurring complications in patients
undergoing surgery with general anesthesia. Nausea and vomiting is a common and
distressing symptom or side effect in medicine, surgery and following
anesthesia. Generally, uncomplicated PONV rarely goes beyond 24 hours
post-operatively and problematic PONV however is more multifactorial in origin
and can be difficult to treat effectively. Patients at risk of this should be
identified by the anesthetist and may be given prophylactic anti-emetic
treatment. Post operative nausea and vomiting (PONV) are one of the complex and
significant problems in anesthesia practice, with the growing trend toward
ambulatory and daycare surgeries. A growing adoption rate of combination
therapies as well as non-pharmacological treatment modes is driving the growth
of the market. Moreover, the surge in funding is expected to boost the growth
of post operative nausea and vomiting (PONV) during the forecast period.
However, strict regulatory approvals and high health care expenditure is
affecting the growth of the market during the forecast period. Moreover, the
launch of newer therapies is anticipated to provide a significant growth
opportunity for the market.
Asia Pacific holds the largest
market shares in the Post-operative Nausea and Vomiting (PONV) Market. A
growing number of patients undergoing surgical procedures and an increase in
compliance to pharmacologic and non-pharmacologic treatments are attributing to
the growth of the market in this region. Furthermore, a large presence of local
pharmaceutical companies in this region is expected to propel market growth in
the Asia Pacific region. Moreover, North America is expected to grow with a
healthy CAGR. The healthcare remuneration in the United States of America (USA)
has transitioned from volume-based systems to value-based systems. This means
healthcare institutions are financially incentivized to provide care according
to evidence-based best practices.
The report on global post
operative nausea and vomiting market covers segments such as treatment type, and
distribution channel. On the basis of treatment type, the sub-markets include
serotonin antagonists, dopamine antagonists, NK-1 receptor antagonists, and
non-pharmacological treatment. On the basis of distribution channel, the
sub-markets include hospital pharmacies, and retail pharmacies & drug
The report provides profiles of
the companies in the market such as Novartis AG, Acacia Pharma, Hoffmann-La
Roche AG, Camurus AB, Sanofi S.A, Helsinn Holding S.A, Eisai Corporation, Merck
and Co, and GlaxoSmithKline Corporation.
The report provides deep insights
into the demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings an insight into the investment areas that existing
or new market players can consider. The report provides insights into the
market using analytical tools such as Porter's five forces analysis and DRO
analysis of post operative nausea and vomiting market. Moreover, the study
highlights current market trends and provides forecast from 2021-2027. We also
have highlighted future trends in the market that will affect the demand during
the forecast period. Moreover, the competitive analysis given in each regional
market brings an insight into the market share of the leading players.